Tag: novavax
This Biotech Penny Stock Has Huge Upside Potential
Novavax (NASDAQ: NVAX) is a clinical stage biotech that focuses on developing recombinant protein nanoparticle vaccines. The company’s vaccine candidates target seasonal influenza, pandemic (H5N1) influenza, and respiratory syncytial virus (RSV). There’s no question that Novavax has exciting vaccine candidates in the clinic. But before you go out and buy the shares, you should […]
